Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement, unanimously ...

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

you should consider Globus Medical (GMED). This company, which is in the Zacks Medical - Instruments industry, shows potential for another earnings beat. This medical device company has seen a ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target ...

Get to Know Globus Medical Better Globus Medical ... musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling ...

Globus Medical, Inc.’s GMED growth in the third ... and unique surgical instruments used in an expansive range of spinal, orthopedic and neurosurgical procedures. The company is particularly ...

Sees FY25 revenue $2.66B-$2.69B, consensus $2.66B. The company said, “The Company established its full year 2025 revenue guidance range of $2.66 billion to $2.69 billion and fully diluted non ...

Globus Medical (NYSE:GMED) said it has agreed to buy Nevro (NVRO) through an all-cash deal with an equity value of around $250M. Under the deal, Globus Medical (NYSE:GMED) will buy all of Nevro's ...